최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Transplant immunology, v.6 no.2, 1998년, pp.69 - 77
Stratta, Robert J (Address for correspondence: RJ Stratta, University of Tennessee-Memphis, Department of Surgery, 956 Court Avenue, Suite A202, Memphis, Tennessee 38163-2116, USA.)
AbstractThrough 1997, over 10 000 pancreas transplants have been performed world-wide, with 88% being simultaneous kidney-pancreas transplants (SKPTs). Current 1-year patient survival exceeds 90% and pancreas graft survival (complete insulin independence) exceeds 80% for SKPT, 70% for sequential pan...
Annu Rev Med Stratta 46 281 1995 10.1146/annurev.med.46.1.281 Pancreas transplantation for diabetes mellitus
Gruessner 47 1994 Pancreas transplantation in the United States (US) and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR)
Surgery Sollinger 102 674 1987 Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression
Transplant Proc Wadstrom 27 1317 1995 Triple versus quadruple induction immunosuppression in pancreas transplantation
Transplant Proc Brayman 26 2525 1994 Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
The International Congress on Immunosuppression, Orlando, Florida Cantarovich 11 1997 Randomized comparison of triple therapy versus anti-thymocyte globulin induction following combined pancreas-renal transplantation
Transplant Proc Stratta 26 546 1994 OKT3-induction in 100 consecutive pancreas transplants
Transplant Proc Stratta 28 917 1996 A prospective randomized trial of OKT3 versus ATGAM-induction therapy in pancreas transplant recipients
Transplant Proc Knechtle 23 1581 1991 OKT3 versus ALG induction therapy in combined pancreas-kidney transplantation
Transplant Proc Ilner 22 1586 1990 Quadruple-drug induction therapy in combined renal and pancreatic transplantation: OKT3 versus ATG
Transplant Proc Sutherland 26 2752 1994 Pancreas transplant outcome with or without biological anti-T cell therapy for induction immunosuppression with use of cyclosporine
Clin Transplant Sutherland 5 549 1991 Immunosuppression for clinical pancreas transplantation
Transplant Proc Rosenberg 29 35S 1997 10.1016/S0041-1345(97)80010-3 Pancreas transplantation with ATG versus OKT3
Transplant Proc Gruessner 26 437 1994 Assessment of donor and recipient risk factors on pancreas transplant outcome
Transplant Proc Brayman 24 91 1992 Factors leading to improved outcome following pancreas transplantation - the influence of immunosuppression and HLA matching
Transplant Proc Shapiro 27 3087 1995 Successful pancreas-renal transplantation without anti-T cell antibody induction
Acta Diabetol Corry 34 125 1997 Tacrolimus without anti-lymphocyte induction therapy prevents pancreas loss from rejection in 100 consecutive patients
Transplantation Van Der Pijl 62 456 1996 10.1097/00007890-199608270-00006 Pharmacokinetics of the conventional and microemulsion formulations of cyclosporine in pancreas-kidney transplant recipients with gastroparesis
Transplant Proc Storck 27 3094 1995 Cyclosporine resorption in diabetic patients after simultaneous pancreas and kidney transplantation
Clin Transplant Lang 3 1 1989 Cyclosporine pharmacokinetics in diabetic patients after kidney and pancreas transplantation
Transplant Proc Serafinowicz 28 3140 1996 Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus treated with Sandimmune and Sandimmune Neoral
Transplant Proc Rigotti 29 2924 1997 10.1016/S0041-1345(97)00731-8 Neoral versus Sandimmune in kidney-pancreas transplantation
Transplantation Chapman 61 1699 1996 10.1097/00007890-199606270-00006 Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplants using a microemulsion formulation
Transplant Proc Dawidson 27 134 1995 Cyclosporine blood levels predict the likelihood of rejection and toxicity after simultaneous pancreas-kidney transplantation
Transplantation Gruessner 61 261 1996 10.1097/00007890-199601270-00018 Multicentre analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation
Clin Transplant Gruessner 11 299 1997 Tacrolimus in pancreas transplantation: a multicentre analysis
Transplantation Hariharan 61 1161 1996 10.1097/00007890-199604270-00007 Rescue therapy with tacrolimus after combined kidney-pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity
Transplant Proc Stratta 28 991 1996 FK506 induction and rescue therapy in pancreas transplant recipients
Transplant Proc Teraoka 27 1335 1995 Effect of rescue therapy using FK506 on relapsing rejection after combined pancreas and kidney transplantation
Transplantation Shaffer 59 1063 1995 10.1097/00007890-199504150-00028 Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506)
Transplant Int Becker 10 51 1997 10.1111/j.1432-2277.1997.tb00536.x Rescue therapy with tacrolimus in simultaneous pancreas-kidney transplantation
Transplant Proc Demirbas 29 2903 1997 10.1016/S0041-1345(97)00723-9 FK506 in simultaneous pancreas/kidney transplantation: The University of Miami experience
Transplant Proc Alloway 28 995 1996 Conversion from cyclosporine to tacrolimus in kidney, kidney-pancreas, and pancreas alone transplant recipients: the Memphis experience
Transplant Proc Burke 27 3123 1995 The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression
Acta Diabetol Peddi 34 162 1997 Use of tacrolimus-based immunosuppression eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation
Ann Surg Bartlett 224 440 1996 10.1097/00000658-199610000-00003 Equivalent success of simultaneous pancreas-kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immuno-suppression with percutaneous biopsy
Transplantation Gruessner 64 1572 1997 10.1097/00007890-199712150-00011 Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus
Transplantation Sollinger 60 225 1995 10.1097/00007890-199508000-00003 Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
Lancet 345 1321 1995 10.1016/S0140-6736(95)92534-1 Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection
American Society of Transplant Physicians, 15th Annual Scientific Meeting, Dallas, TX Stratta 26291996 Mycophenolate mofetil (MMF) induction and conversion therapy in pancreas transplant recipients
Acta Diabetol Elkhammas 34 161 1997 Combined kidney/pancreas transplantation: comparison of mycophenolate mofetil versus azathioprine
Transplantation Odorico 65 240(645A) 1998 10.1097/00007890-199805131-00642 A study comparing mycophenlate mofetil to azathioprine in simultaneous pancreas-kidney transplantation
Acta Diabetol Gritsch 34 162 1997 Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation
American Society of Transplant Physicians, 16th Annual Scientific Meeting. Chicago, IL Marcos 10141997 Mycophenolate mofetil is associated with decreased incidence of severity of acute cellular rejection following simultaneous kidney/pancreas transplant
Transplant Proc Stratta 29 654 1997 10.1016/S0041-1345(96)00383-1 Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multicentre report
Acta Diabetol Gruessner 34 125 1997 Mycophenolate mofetil and tacrolimus in pancreas transplantation
Transplantation Stegall 64 1695 1997 10.1097/00007890-199712270-00011 Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine
Transplantation Reddy 65 251(691A) 1998 10.1097/00007890-199805131-00688 Simultaneous kidney-pancreas transplantation without anti-lymphocyte induction
Acta Diabetol Bruce 34 161 1997 Effects of tacrolimus, mycophenolate mofetil, and microemulsified cyclosporine on rejection incidence in synchronous pancreas/kidney transplantation
Transplant Proc Burke 36 1544 1998 10.1016/S0041-1345(98)00350-9 The use of tacrolimus and mycophenolate mofetil for pancreas/kidney transplantation with or without OKT3 induction
Acta Diabetol Busing 34 126 1997 Mycophenolate mofetil/tacrolimus/single shot ATG versus azathioprine/cyclosporine in pancreas-kidney transplantation: Results of a prospective randomized single-center study
Acta Diabetol Kaufman 34 120 1997 Results with tacrolimus/mycophenolate mofetil primary maintenance immunosuppression in simultaneous pancreas/kidney transplantation
Acta Diabetol Kahl 34 162 1997 First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation
American Society of Transplant Surgeons, 23rd Annual Scientific Meeting, Chicago, IL Lee 14161997 FK506 and mycophenolate mofetil: the superior strategy for simultaneous pancreas-kidney patients
Transplant Immunol Zucker 5 225 1997 10.1016/S0966-3274(97)80042-1 Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings
J Invest Med Larsen 42 622 1994 Consequences of pancreas transplantation
Curr Probl Surg Stratta 33 709 1996 10.1016/S0011-3840(96)80006-2 Pancreas transplantation: a managed cure approach to diabetes
Transpl Proc Cantarovich 23 2224 1991 Maintenance immunosuppression without corticosteroids following combined pancreas and kidney transplantation
Transplantation Hricik 54 868 1992 10.1097/00007890-199211000-00019 The effects of steroid withdrawal on the lipoprotein in profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients
Acta Diabetol Elmer 34 118 1997 Tacrolimus versus cyclosporin A: effects on glucose utilization in portally drained pancreas allografts
N Engl J Med Tyden 335 860 1996 10.1056/NEJM199609193351205 Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts
Trans Assoc Am Physicians Sutherland 97 80 1984 Twin-to-twin pancreas transplantation: reversal and re-enactment of the pathogenesis of Type I diabetes
Transplantation Larsen 56 1533 1993 Evidence that fasting hyperproinsulinemia after combined pancreas-kidney transplantation diminishes over time
Diabetes Diem 39 534 1990 10.2337/diabetes.39.5.534 Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients
Diabetes Care Milde 18 93 1995 10.2337/diacare.18.1.93 Pancreatic transplantation: impact on the quality of life of diabetic renal transplant recipients
Transplant Proc Hathaway 27 3065 1995 Identification of quality-of-life outcomes distinguishing diabetic kidney-alone and pancreas-kidney recipients
Diabetologica Zehrer 34 S145 1991 10.1007/BF00587643 Quality-of-life of pancreas transplant recipients
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.